Extreme myeloid cell compartment changes during COVID-19 were also reported by a multipronged approach characterized by an elevation in HLA-DRhiCD11chi/HLA-DRhiCD83hi inflammatory monocytes with a strong antiviral IFN-signature in mild COVID-19 patients. Here, IFNA1 is linked to COVID-19.